do compounded glp-1 drugs work Safety: Supervised Weightloss Medications GLP-1 Medications for Weight Loss:

The latest International Diabetes Federation (IDF) report indicates a 10.5% prevalence of T2DM in adults in 2021, projected to reach 12.2% by 2045 (Sun et al., 2022

caution is needed for patients with a history of medullary thyroid cancer

Earlier in March, FDA released a similar announcement ending the compounding of tirzepatide (a GLP-1 drug used in Mounjaro & Zepbound)

Novo Nordisk to slash list prices of Ozempic, Wegovy by up to 50% Ozempic and Wegovy prices will drop by 35% and 50%, respectively, in 2027 as company faces growing competition from cheaper alternatives Novo Nordisk on Tuesday announced plans to cut the list price of its popular diabetes and weight-loss drugs Ozempic and Wegovy by as much as 50% in the U.S

over allegations that the latter is still trying to mass-market cheaper versions of the GLP-1 drugs

J Clin Endocrinol Metab (2020) 105(3):80320